Arthur Dresdale is a notable inventor based in Plainfield, NJ (US). He has made significant contributions to the field of medical technology, particularly in the preparation of cryoprecipitated suspensions. With a total of 2 patents to his name, his work has the potential to impact surgical procedures positively.

Latest Patents

Dresdale's latest patents focus on methods for preparing cryoprecipitated suspensions containing fibrinogen and Factor XIII. The first patent describes a method that involves freezing fresh frozen plasma from a single donor, such as a human or animal, at approximately -80 degrees Celsius for at least six hours. This process results in a supernatant and a cryoprecipitated suspension that can be recovered for use. The second patent elaborates on a similar method, emphasizing the preparation of fibrin glue useful in surgical procedures. This involves applying a defined volume of the cryoprecipitated suspension to a surgical site and introducing a thrombin-containing composition to convert fibrinogen into a solidifying gel.

Career Highlights

Arthur Dresdale is affiliated with Columbia University, where he continues to advance his research and innovations in medical technology. His work is crucial in developing effective surgical adhesives that can enhance patient outcomes.

Collaborations

Dresdale collaborates with Eric A. Rose, contributing to the advancement of their shared research interests in medical applications.

Conclusion

Arthur Dresdale's innovative work in cryoprecipitation techniques showcases his commitment to improving surgical practices. His patents reflect a significant advancement in the preparation of fibrin glue, which has the potential to enhance surgical procedures and patient care.